GENEVA, July 2 -- HANGZHOU BAICREAT PHARMA-TECH CO., LTD. filed a patent application (CN2025/143924) for “PTPN2/PTPN1 INHIBITOR, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF”. With publication no. WO/2026/130528, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 285/10
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....